Conditioned fear is modulated by CRF mechanisms in the periaqueductal gray columns

Hormones and Behavior

Volumn 63, Issue 5, 2013, Pages 791-799

  Borelli, Karina G ^a,b,c   Albrechet Souza, Lucas ^a,b   Fedoce, Alessandra G ^b   Fabri, Denise S ^b   Resstel, Leonardo B ^b   Brandão, Marcus L ^a,b  

^a Instituto de Neuroci ncias e Comportamento   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE FEDERAL DO ABC   (Brazil)

Author keywords

Autonomic responses; Contextual fear conditioning; Corticotropin releasing factor; Fear potentiated startle; Nonmonotonic effects; Periaqueductal gray

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTERIAL PRESSURE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BODY TEMPERATURE; BRAIN REGION; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; COORDINATION; FEAR; FOOTSHOCK; HEART RATE; HORMONE RESPONSE; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; STARTLE REFLEX; STRESS; TAIL;

ANIMALS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; CONDITIONING, CLASSICAL; CORTICOTROPIN-RELEASING HORMONE; FEAR; FREEZING REACTION, CATALEPTIC; HEART RATE; MALE; PERIAQUEDUCTAL GRAY; RATS; RATS, WISTAR; STARTLE REACTION;

EID: 84878237030     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2013.04.001     Document Type: Article

References (93)

1. Albrechet-Souza L., Borelli K.G., Carvalho M.C., Brandão M.L. The anterior cingulate cortex is a target structure for the anxiolytic-like effects of benzodiazepines assessed by repeated exposure to the elevated plus maze and Fos immunoreactivity. Neuroscience 2009, 164:387-397.
2. Antoniadis E.A., McDonald R.J. Discriminative fear conditioning to context expressed by multiple measures of fear in the rat. Behav. Brain Res. 1999, 101:1-13.
3. Antoniadis E.A., Winslow J.T., Davis M., Amaral D.G. The nonhuman primate amygdala is necessary for the acquisition but not the retention of fear-potentiated startle. Biol. Psychiatry 2009, 65:241-248.
4. Bakshi V.P., Kalin N.H. Corticotropin-releasing hormone and animal models of anxiety: gene-environment interactions. Biol. Psychiatry 2000, 15(48):1175-1198.
5. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat. Genet. 2000, 24:410-414.
6. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
7. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?. Trends Neurosci. 1994, 17:379-389.
8. Bijlsma E.Y., van Leeuwen M.L., Westphal K.G., Olivier B., Groenink L. Local repeated corticotropin-releasing factor infusion exacerbates anxiety- and fear-related behavior: differential involvement of the basolateral amygdala and medial prefrontal cortex. Neuroscience 2011, 26:82-92.
9. Blanchard R.J., Blanchard D.C. Passive and active reactions to fear-eliciting stimuli. J. Comp. Physiol. Psychol. 1969, 68:129-135.
10. Blanchard R.J., Yudko E.B., Rodgers R.J., Blanchard D.C. Defense system psychopharmacology: an ethological approach to the pharmacology of fear and anxiety. Behav. Brain Res. 1993, 20:155-165.
11. Borelli K.G., Brandão M.L. Effects of ovine CRF injections into the dorsomedial, dorsolateral and lateral columns of the periaqueductal gray: a functional role for the dorsomedial column. Horm. Behav. 2008, 53:40-50.
12. Borelli K.G., Nobre M.J., Brandão M.L., Coimbra N.C. Effects of acute and chronic fluoxetine and diazepam on freezing behavior induced by electrical stimulation of dorsolateral and lateral columns of the periaqueductal gray matter. Pharmacol. Biochem. Behav. 2004, 77:557-566.
13. Borelli K.G., Gárgaro A.C., dos Santos J.M., Brandão M.L. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning. Neurosci. Lett. 2005, 21:105-110.
14. Bouton M.E., Bolles R.C. Role of conditioned contextual stimuli in reinstatement of extinguished fear. J. Exp. Psychol. Anim. Behav. Process. 1979, 5:368-378.
15. Bowers L.K., Swisher C.B., Behbehani M.M. Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat. Brain Res. 2003, 15(981):52-57.
16. Boyson C.O., Miguel T.T., Quadros I.M., Debold J.F., Miczek K.A. Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology 2011, 218:257-269.
17. Brandão M.L., Anseloni V.Z., Pandóssio J.E., De Araújo J.E., Castilho V.M. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain. Neurosci. Biobehav. Rev. 1999, 23:863-875.
18. Brandão M.L., Borelli K.G., Nobre M.J., Santos J.M., Albrechet-Souza L., Oliveira A.R., Martinez R.C. Gabaergic regulation of the neural organization of fear in the midbrain tectum. Neurosci. Biobehav. Rev. 2005, 29:1299-1311.
19. Carrive P. The periaqueductal gray and defensive behavior: functional representation and neuronal organization. Behav. Brain Res. 1993, 20(58):27-47.
20. Carvalho-Netto E.F., Litvin Y., Nunes-de-Souza R.L., Blanchard D.C., Blanchard R.J. Effects of intra-PAG infusion of ovine CRF on defensive behaviors in Swiss-Webster mice. Behav. Brain Res. 2007, 25(176):222-229.
21. Coimbra N.C., De Oliveira R., Freitas R.L., Ribeiro S.J., Borelli K.G., Pacagnella R.C., Moreira J.E., da Silva L.A., Melo L.L., Lunardi L.O., Brandão M.L. Neuroanatomical approaches of the tectum-reticular pathways and immunohistochemical evidence for serotonin-positive perikarya on neuronal substrates of the superior colliculus and periaqueductal gray matter involved in the elaboration of the defensive behavior and fear-induced analgesia. Exp. Neurol. 2006, 197:93-112.
22. Conti L.H. Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains. Neuropharmacology 2012, 62:256-263.
23. Davis M., Falls W.A., Campeau S., Kim M. Fear-potentiated startle: a neural and pharmacological analysis. Behav. Brain Res. 1993, 20(58):175-198.
24. de Jongh R., Groenink L., van der Gugten J., Olivier B. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone. Biol. Psychiatry 2003, 54:1041-1048.
25. de Kloet C.S., Vermetten E., Geuze E., Lentjes E.G., Heijnen C.J., Stalla G.K., Westenberg H.G. Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Prog. Brain Res. 2008, 167:287-291.
26. de Oliveira A.R., Reimer A.E., Reis F.M., Brandão M.L. Conditioned fear response is modulated by a combined action of the hypothalamic-pituitary-adrenal axis and dopamine activity in the basolateral amygdala. Eur. Neuropsychopharmacol. 2012, (Epub ahead of print).
27. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J. Neurosci. 1985, 5:3189-3203.
28. Dean C. Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 300:771-779.
29. Dong H.W., Swanson L.W. Projections from bed nuclei of the stria terminalis, posterior division: implications for cerebral hemisphere regulation of defensive and reproductive behaviors. J. Comp. Neurol. 2004, 12(471):396-433.
30. Dong H.W., Petrovich G.D., Swanson L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev. 2001, 38:192-246.
31. Fanselow M.S., Tighe T.J. Contextual conditioning with massed versus distributed unconditional stimuli in the absence of explicit conditional stimuli. J. Exp. Psychol. Anim. Behav. Process. 1988, 14:187-199.
32. Fendt M., Koch M., Schnitzler H.U. Lesions of the central gray block the sensitization of the acoustic startle response in rats. Brain Res. 1994, 24(661):163-173.
33. Fisher L.A., Jessen G., Brown M.R. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Regul. Pept. 1983, 5:153-161.
34. Gordon C.J. Thermal biology of the laboratory rat. Physiol. Behav. 1990, 47:963-991.
35. Gray T.S., Magnuson D.J. Peptide immunoreactive neurons in the amygdala and the bed nucleus of the stria terminalis project to the midbrain central gray in the rat 1992, 13:451-460.
36. Gresack J.E., Risbrough V.B. Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity. Int. J. Neuropsychopharmacol. 2011, 14:1179-1194.
37. Griebel G. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?. Pharmacol. Ther. 1999, 82:1-61.
38. Grillon C., Baas J. A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin. Neurophysiol. 2003, 114:1557-1579.
39. Hauger R.L., Risbrough V.B., Brauns O., Dautzenberg F.M. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol. Disord. Drug Targets 2006, 5:453-479.
40. Hubbard D.T., Nakashima B.R., Lee I., Takahashi L.K. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 2007, 150:818-828.
41. Keay K.A., Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci. Biobehav. Rev. 2001, 25:669-678.
42. Keck M.E., Kern N., Erhardt A., Unschuld P.G., Ising M., Salyakina D., Müller M.B., Knorr C.C., Lieb R., Hohoff C., Krakowitzky P., Maier W., Bandelow B., Fritze J., Deckert J., Holsboer F., Müller-Myhsok B., Binder E.B. Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 5(147B):1196-1204.
43. Kim J.J., Fanselow M.S. Modality-specific retrograde amnesia of fear. Science 1992, 1(256):675-677.
44. Kim J.J., Rison R.A., Fanselow M.S. Effects of amygdala, hippocampus and periaqueductal gray lesions on short- and long-term contextual fear. Behav. Neurosci. 1993, 107:1093-1098.
45. Kishimoto T., Radulovic J., Radulovic M., Lin C.R., Schrick C., Hooshmand F., Hermanson O., Rosenfeld M.G., Spiess J. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat. Genet. 2000, 24:415-419.
46. Koch M. The neurobiology of startle Prog. Neurobiology 1999, 59:107-128.
47. Koob G.F., Heinrichs S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res. 1999, 27(848):141-152.
48. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 1988, 8:2517-2529.
49. Lee Y., Davis M. Role of the hippocampus, the bed nucleus of the stria terminalis and the amygdala in the excitatory effect of corticotropin-releasing hormone on the acoustic startle reflex. J. Neurosci. 1997, 17:6434-6446.
50. Lisboa S.F., Reis D.G., da Silva A.L., Corrêa F.M., Guimarães F.S., Resstel L.B. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int. J. Neuropsychopharmacol. 2010, 13:1163-1173.
51. Litvin Y., Pentkowski N.S., Blanchard D.C., Blanchard R.J. CRF type 1 receptors in the dorsal periaqueductal gray modulate anxiety-induced defensive behaviors. Horm. Behav. 2007, 52:244-251.
52. Lovick T.A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats. Pain 1985, 21:241-252.
53. Martins A.P., Marras R.A., Guimarães F.S. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey. Neuroreport 1997, 10(8):3601-3604.
54. Martins A.P., Marras R.A., Guimarães F.S. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray. Depress. Anxiety 2000, 12:99-101.
55. McGaugh J.L. Hormonal influences on memory. Ann. Rev. Psychol. 1983, 27:297-323.
56. Merchenthaler I. Corticotropin releasing factor (CRF)-like immunoreactivity in the rat central nervous system. Extrahypothalamic distribution. Peptides 1984, 5:53-69.
57. Miguel T.T., Nunes-de-Souza R.L. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Horm. Behav. 2011, 60:292-300.
58. Momose K., Inui A., Asakawa A., Ueno N., Nakajima M., Fujimiya M., Kasuga M. Intracerebroventricularly administered corticotropin-releasing factor inhibits food intake and produces anxiety-like behaviour at very low doses in mice. Diabetes Obes. Metab. 1999, 1:281-284.
59. Morimoto A., Nakamori T., Morimoto K., Tan H., Murakami N. The central role of corticotropin-releasing factor (CRF-41) in psychological stress in rats. J. Physiol. 1993, 460:221-229.
60. Netto C.F., Guimarães F.S. Anxiogenic effect of cholecystokinin in the dorsal periaqueductal gray. Neuropsychopharmacology 2004, 29:101-107.
61. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 1991, 43:425-473.
62. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Academic Press, Sydney.
63. Pentkowski N.S., Litvin Y., Blanchard D.C., Vasconcellos A., King L.B., Blanchard R.J. Effects of acidic-astressin and ovine-CRF microinfusions into the ventral hippocampus on defensive behaviors in rats. Horm. Behav. 2009, 56:35-43.
64. Phillips R.G., LeDoux J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 1992, 106:274-285.
65. Pitts M.W., Takahashi L.K. The central amygdala nucleus via corticotropin-releasing factor is necessary for time-limited consolidation processing but not storage of contextual fear memory. Neurobiol. Learn. Mem. 2011, 95:86-91.
66. Price M.T.C., Cooper R.M. U-shaped functions in a shock escape task. J. Comp. Physiol. Psychol. 1975, 80:600-606.
67. Rea K., Roche M., Finn D.P. Modulation of conditioned fear, fear-conditioned analgesia and brain regional c-Fos expression following administration of muscimol into the rat basolateral amygdala. J. Pain 2011, 12:712-721.
68. Reimer A.E., Oliveira A.R., Brandão M.L. Selective involvement of GABAergic mechanisms of the dorsal periaqueductal gray and inferior colliculus on the memory of the contextual fear as assessed by the fear potentiated startle test. Brain Res. Bull. 2008, 30(76):545-550.
69. Reimer A.E., de Oliveira A.R., Brandão M.L. Glutamatergic mechanisms of the dorsal periaqueductal gray matter modulate the expression of conditioned freezing and fear-potentiated startle. Neuroscience 2012, 6:72-81.
70. Resstel L.B., Joca S.R., Guimarães F.G., Corrêa F.M. Involvement of medial prefrontal cortex neurons in behavioral and cardiovascular responses to contextual fear conditioning. Neuroscience 2006, 1(143):377-385.
71. Reul J.M., Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2002, 2:23-33.
72. Risbrough V.B., Hauger R.L., Pelleymounter M.A., Geyer M.A. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology 2003, 170:178-187.
73. Risbrough V.B., Hauger R.L., Roberts A.L., Vale W.W., Geyer M.A. Corticotropin releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J. Neurosci. 2004, 24:6545-6552.
74. Risbrough V.B., Geyer M.A., Hauger R.L., Coste S., Stenzel-Poore M., Wurst W., Holsboer F. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology 2009, 34:1494-1503.
75. Rudy J.W. Contextual conditioning and auditory cue conditioning dissociate during development. Behav. Neurosci. 1993, 107:887-891.
76. Sautter F.J., Bissette G., Wiley J., Manguno-Mire G., Schoenbachler B., Myers L., Johnson J.E., Cerbone A., Malaspina D. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD and healthy control subjects. Biol. Psychiatry 2003, 54:1382-1388.
77. Schulz D.W., Mansbach R.S., Sprouse J., Braselton J.P., Collins J., Corman M., Dunaiskis A., Faraci S., Schmidt A.W., Seeger T., Seymour P., Tingley F.D., Winston E.N., Chen Y.L., Heym J. CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:10477-10482.
78. Sink K.S., Walker D.L., Freeman S.M., Flandreau E.I., Ressler K.J., Davis M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol. Psychiatry 2012, 1-12.
79. Smoller J.W., Yamaki L.H., Fagerness J.A., Biederman J., Racette S., Laird N.M., Kagan J., Snidman N., Faraone S.V., Hirshfeld-Becker D., Tsuang M.T., Slaugenhaupt S.A., Rosenbaum J.F., Sklar P.B. The corticotropin-releasing hormone gene and behavioral inhibition in children at risk for panic disorder. Biol. Psychiatry 2005, 15(57):1485-1492.
80. Steckler T., Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol. Psychiatry 1999, 46(11):1480-1508.
81. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
82. Swerdlow N.R., Britton K.T., Koob G.F. Potentiation of acoustic startle by corticotropin-releasing factor (CRF) and by fear are both reversed by alpha-helical CRF (9-41). Neuropsychopharmacology 1989, 2:285-292.
83. Todorovic C., Radulovic J., Jahn O., Radulovic M., Sherrin T., Hippel C., Spiess J. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety. Eur. J. Neurosci. 2007, 25:3385-3397.
84. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
85. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R.Jr, Lee D.H., Shioda T., Soto A.M., vom Saal F.S., Welshons W.V., Zoeller R.T., Myers J.P. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33:378-455.
86. Vieira E.B., Menescal-de-Oliveira L., Leite-Panissi C.R. Functional mapping of the periaqueductal gray matter involved in organizing tonic immobility behavior in guinea pigs. Behav. Brain Res. 2011, 216:94-99.
87. Walker P., Carrive P. Role of ventrolateral periaqueductal gray neurons in the behavioral and cardiovascular responses to contextual conditioned fear and poststress recovery. Neuroscience 2003, 116:897-912.
88. Walker D.L., Miles L.A., Davis M. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:1291-1308.
89. Wöhr M., Borta A., Schwarting R.K. Overt behavior and ultrasonic vocalization in a fear conditioning paradigm: a dose-response study in the rat. Neurobiol. Learn. Mem. 2005, 2005(84):228-240.
90. Yang M., Farrokhi C., Vasconcellos A., Blanchard R.J., Blanchard D.C. Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB). Behav. Brain Res. 2006, 15(171):1-8.
91. Yeomans J.S., Li L., Scott B.W., Frankland P.W. Tactile, acoustic and vestibular systems sum to elicit the startle reflex. Neurosci. Biobehav. Rev. 2002, 26:1-11.
92. Zanoveli J.M., Ferreira-Netto C., Brandão M.L. Conditioned place aversion organized in the dorsal periaqueductal gray recruits the laterodorsal nucleus of the thalamus and the basolateral amygdala. Exp. Neurol. 2007, 208:127-136.
93. Zhao Z., Yang Y., Walker D.L., Davis M. Effects of substance P in the amygdala, ventromedial hypothalamus and periaqueductal gray on fear-potentiated startle. Neuropsychopharmacology 2009, 34:331-340.